News
-
-
-
PRESS RELEASE
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis